Literature DB >> 1983726

Benzodiazepine use by chronic pain patients.

S A King1, J J Strain.   

Abstract

Of 114 patients presenting to the Pain Management Service at the Mount Sinai School of Medicine with chronic pain, 38% (N = 43) were taking one or more benzodiazepine drugs at the time of the initial assessment. The majority of patients were chronic users, with 14% (N = 6) having taken the medications for 1-2 years and 46% (N = 20) for 2 years or longer. Ninety-three percent (N = 40) of those given a benzodiazepine drug stated that it was initiated after the onset of pain. Although 86% (N = 37) were using the medication (all or in part) to improve sleep, they continued to report as many problems with sleep as the nonbenzodiazepine group did. Other drugs prescribed concurrently with the benzodiazepine drugs were narcotic drugs (58% of patients), antidepressant drugs (32%), nonsteroidal antiinflammatory agents (26%), and others (16%). Benzodiazepines have been reported to provide little therapeutic benefit to chronic pain patients, and may even exacerbate their symptoms. We have shown that benzodiazepine drugs are frequently prescribed for long-term use, for sleep, and in conjunction with narcotic drugs. Such use is contrary to generally accepted guidelines.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1983726     DOI: 10.1097/00002508-199006000-00013

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  11 in total

1.  Use of tranquilizers and sleeping pills among cancer patients is associated with a poorer quality of life.

Authors:  O Paltiel; A Marzec-Boguslawska; V Soskolne; S Massalha; M Avitzour; R Pfeffer; N Cherny; T Peretz
Journal:  Qual Life Res       Date:  2004-12       Impact factor: 4.147

2.  Evaluation of a cognitive behavioural programme for rehabilitating patients with chronic pain.

Authors:  A C Williams; M K Nicholas; P H Richardson; C E Pither; D M Justins; J H Chamberlain; V R Harding; J A Ralphs; S C Jones; I Dieudonné
Journal:  Br J Gen Pract       Date:  1993-12       Impact factor: 5.386

Review 3.  Risks, management, and monitoring of combination opioid, benzodiazepines, and/or alcohol use.

Authors:  Jeffrey A Gudin; Shanthi Mogali; Jermaine D Jones; Sandra D Comer
Journal:  Postgrad Med       Date:  2013-07       Impact factor: 3.840

4.  Insomnia Co-Occurring with Chronic Pain: Clinical Features, Interaction, Assessments and Possible Interventions.

Authors:  Nicole K Y Tang
Journal:  Rev Pain       Date:  2008-09

Review 5.  Polydrug abuse: a review of opioid and benzodiazepine combination use.

Authors:  Jermaine D Jones; Shanthi Mogali; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2012-08-02       Impact factor: 4.492

6.  Pain and psychiatry: a critical analysis and pharmacological review.

Authors:  Donatella Marazziti; Francesco Mungai; Laura Vivarelli; Silvio Presta; Bernardo Dell'Osso
Journal:  Clin Pract Epidemiol Ment Health       Date:  2006-11-06

7.  Benzodiazepine use in patients with chronic pain in an interdisciplinary pain rehabilitation program.

Authors:  Julie L Cunningham; Julia R Craner; Michele M Evans; W Michael Hooten
Journal:  J Pain Res       Date:  2017-02-09       Impact factor: 3.133

8.  Co-prescription of opioids with benzodiazepine and other co-medications among opioid users: differential in opioid doses.

Authors:  Che Suraya Zin; Fadhilah Ismail
Journal:  J Pain Res       Date:  2017-01-25       Impact factor: 3.133

9.  Home-based virtual reality for chronic pain: protocol for an NIH-supported randomised-controlled trial.

Authors:  Brandon Birckhead; Sam Eberlein; Genie Alvarez; Rebecca Gale; Taylor Dupuy; Katherine Makaroff; Garth Fuller; Xiaoyu Liu; Kyung-Sang Yu; J T Black; Mariko Ishimori; Swamy Venuturupalli; Joseph Tu; Tom Norris; Mourad Tighiouart; Lindsey Ross; Karma McKelvey; Mark Vrahas; Itai Danovitch; Brennan Spiegel
Journal:  BMJ Open       Date:  2021-06-15       Impact factor: 3.006

10.  Chronic Pain and Sleep Disorders in Primary Care.

Authors:  Robert Jank; Alexander Gallee; Markus Boeckle; Sabine Fiegl; Christoph Pieh
Journal:  Pain Res Treat       Date:  2017-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.